An investigation for investors in Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) shares over potential securities laws violations by Invivo Therapeutics Holdings was announced and NASDAQ:NVIV stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 08/09/2017 -- Invivo Therapeutics Holdings is under investigation over possible securities laws violations. The investigation was announced for investors in NASDAQ:NVIV shares in connection with certain financial statements made by Invivo Therapeutics Holdings.
Investors who purchased shares of Invivo Therapeutics Holdings Corp (NASDAQ:NVIV), have certain options and should contact the Shareholders Foundation at email@example.com or call 858-779-1554.
The investigation by a law firm focuses on whether certain statements by Invivo Therapeutics Holdings regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On July 31, 2017, Invivo Therapeutics Holdings Corp revealed that after a third patient death, it had stopped a trial of its Neuro-Spinal Scaffold, a spinal cord injury treatment and advised investors that the it had decided to stop the trial while it discusses with the U.S. Food and Drug Administration whether to change the trial's enrollment criteria.
Those who purchased shares of Invivo Therapeutics Holdings Corp (NASDAQ:NVIV), have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels